Autoimmune hemolytic anemia in children: Clinical presentation and treatment outcome
BACKGROUND: Autoimmune hemolytic anemias (AIHA) are characterized by the destruction of red cells following the production of autoantibodies directed against them. Although AIHA in children is usually self-limiting, many still succumb to the illness due to delay in the diagnosis and treatment. AIHA...
Enregistré dans:
Auteurs principaux: | Satyam Arora, Seema Dua, Nita Radhakrishnan, Savitri Singh, Jyotsna Madan, Devajit Nath |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Wolters Kluwer Medknow Publications
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/3e58b49f2cca440dbaa785dfe30ed5e6 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Blood group discrepancy in mixed-type autoimmune hemolytic anemia in a pediatric patient
par: Minal Wasnik, et autres
Publié: (2021) -
Bortezomib in autoimmune hemolytic anemia and beyond
par: Raffaella Pasquale, et autres
Publié: (2021) -
A New Murine Model of Primary Autoimmune Hemolytic Anemia (AIHA)
par: Flavia Dei Zotti, et autres
Publié: (2021) -
First report of expansion of CD4+/CD28 null T-helper lymphocytes in adult patients with idiopathic autoimmune hemolytic anemia
par: Soha R. Youssef, et autres
Publié: (2021) -
RECURRENT AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MRNA COVID-19 VACCINE (PFIZER-BIONTECH)
par: Fatma YILMAZ, et autres
Publié: (2021)